RAMPs and G protein coupled receptors

被引:5
作者
Cueille, C [1 ]
Garel, JM [1 ]
机构
[1] Hop Lariboisiere, INSERM, U 349, F-75475 Paris 10, France
来源
M S-MEDECINE SCIENCES | 2004年 / 20卷 / 8-9期
关键词
D O I
10.1051/medsci/2004208-9773
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
RAMPs (receptor activity-modifying proteins) were discovered in 1998 as accessory proteins needed to the functionnal activity of CGRP (colcitonin gene-related peptide) receptors. Three RAMPs generated by three different genes are known in human, rat and mice. The coding sequences of such genes are described, but as yet, regulation sequences are unknown. RAMPs interact with GPCR (G protein-coupled receptors) of class II. In the case of the calcitonin/CGRP peptide family, RAMPs determine the functionnal specificity of the receptor, glycosylate and translocate the receptor to the cell surface. CGRP receptors are observed in presence of the RAMP1/calcitonin receptor-like receptor (CRLR), but the association of RAMP2 or RAMP3 with CRLR generates an adrenomedullin receptor. The calcitonin receptor (CTR) is translocated alone to the cell surface, but interactions of RAMPs with CTR forms amylin receptors. If RAMPs can interact with glucagon, parathyroid hormone and VIP/PACAP (vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide (VPACR1)) receptors, the functionnal specificity of these receptors remains unaltered. However, the complex VPACR1/RAMP2 enhances specifically the phosphoinoside signaling pathway.
引用
收藏
页码:773 / 778
页数:6
相关论文
共 41 条
[1]   Mammalian calcitonin receptor-like receptor/receptor activity modifying protein complexes define calcitonin gene-related peptide and adrenomedullin receptors in Drosophila Schneider 2 cells [J].
Aldecoa, A ;
Gujer, R ;
Fischer, JA ;
Born, W .
FEBS LETTERS, 2000, 471 (2-3) :156-160
[2]   Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor [J].
Armour, SL ;
Foord, S ;
Kenakin, T ;
Chen, WJ .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1999, 42 (04) :217-224
[3]   G protein-coupled receptor interacting proteins: Emerging roles in localization and signal transduction [J].
Brady, AE ;
Limbird, LE .
CELLULAR SIGNALLING, 2002, 14 (04) :297-309
[4]   Glycosylation of the calcitonin receptor-like receptor at Asn60 or Asn112 is important for cell surface expression [J].
Bühlmann, N ;
Aldecoa, A ;
Leuthäuser, K ;
Gujer, R ;
Muff, R ;
Fischer, JA ;
Born, W .
FEBS LETTERS, 2000, 486 (03) :320-324
[5]   CGRP and adrenomedullin binding correlates with transcript levels for Calcitonin Receptor-Like Receptor (CRLR) and Receptor Activity Modifying Proteins (RAMPs) in rat tissues [J].
Chakravarty, P ;
Suthar, TP ;
Coppock, HA ;
Nicholl, CG ;
Bloom, SR ;
Legon, S ;
Smith, DM .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (01) :189-195
[6]   Evidence for the existence of a new receptor for CGRP, which is not CRLR [J].
Chauhan, M ;
Thota, CS ;
Kondapaka, S ;
Wimalawansa, S ;
Yallampalli, C .
PEPTIDES, 2003, 24 (01) :65-71
[7]   Novel receptor partners and function of receptor activity-modifying proteins [J].
Christopoulos, A ;
Christopoulos, G ;
Morfis, M ;
Udawela, M ;
Laburthe, M ;
Couvineau, A ;
Kuwasako, K ;
Tilakaratne, N ;
Sexton, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) :3293-3297
[8]   Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product [J].
Christopoulos, G ;
Perry, KJ ;
Morfis, M ;
Tilakaratne, N ;
Gao, YY ;
Fraser, NJ ;
Main, MJ ;
Foord, SM ;
Sexton, PM .
MOLECULAR PHARMACOLOGY, 1999, 56 (01) :235-242
[9]   Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure [J].
Cueille, C ;
Pidoux, E ;
de Vernejoul, MC ;
Ventura-Clapier, R ;
Garel, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 294 (02) :340-346
[10]  
DENNIS T, 1990, J PHARMACOL EXP THER, V254, P123